NASDAQ:PDEX - Nasdaq - US74265M2052 - Common Stock - Currency: USD
NASDAQ:PDEX (2/28/2025, 8:07:35 PM)
34.72
+0.99 (+2.94%)
The current stock price of PDEX is 34.72 USD. In the past month the price decreased by -19.16%. In the past year, price increased by 106.54%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 29.55 | 239.37B | ||
ISRG | INTUITIVE SURGICAL INC | 78.19 | 204.42B | ||
BSX | BOSTON SCIENTIFIC CORP | 41.35 | 152.97B | ||
SYK | STRYKER CORP | 31.68 | 147.22B | ||
MDT | MEDTRONIC PLC | 17.23 | 118.00B | ||
BDX | BECTON DICKINSON AND CO | 16.21 | 64.76B | ||
EW | EDWARDS LIFESCIENCES CORP | 27.34 | 42.24B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 19.45 | 39.91B | ||
IDXX | IDEXX LABORATORIES INC | 38.85 | 35.79B | ||
DXCM | DEXCOM INC | 53.56 | 34.52B | ||
RMD | RESMED INC | 26.42 | 34.30B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 17.83 | 24.47B |
Pro-Dex, Inc. engages in the design, development and manufacture of rotary drive surgical and dental instruments. The company is headquartered in Irvine, California and currently employs 148 full-time employees. The firm has patented adoptive torque-limiting software and sealing solutions, which appeal to its customers, primarily medical device distributors. The company also manufactures and sells rotary air motors to a range of industries. The Company’s medical device products utilize designs developed by it primarily under development and supply agreements and are machined in its Irvine, California facility, and assembled in its Tustin, California facility, as are its rotary air motors. Its medical device products are sold primarily to original equipment manufacturers and its air motors are sold primarily to a range of distributors and end users. The company has an approximately 25,000 square foot industrial building in Tustin, California (the Franklin Property).
PRO-DEX INC
2361 McGaw Ave
Irvine CALIFORNIA 92614 US
CEO: Richard L. Van Kirk
Employees: 148
Company Website: https://www.pro-dex.com/
Investor Relations: http://www.pro-dex.com/investor-relations/
Phone: 19497693200
The current stock price of PDEX is 34.72 USD. The price increased by 2.94% in the last trading session.
The exchange symbol of PRO-DEX INC is PDEX and it is listed on the Nasdaq exchange.
PDEX stock is listed on the Nasdaq exchange.
7 analysts have analysed PDEX and the average price target is 53.04 USD. This implies a price increase of 52.76% is expected in the next year compared to the current price of 34.72. Check the PRO-DEX INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
PRO-DEX INC (PDEX) has a market capitalization of 113.19M USD. This makes PDEX a Micro Cap stock.
PRO-DEX INC (PDEX) currently has 148 employees.
PRO-DEX INC (PDEX) has a support level at 32.51 and a resistance level at 36.19. Check the full technical report for a detailed analysis of PDEX support and resistance levels.
The Revenue of PRO-DEX INC (PDEX) is expected to grow by 23.48% in the next year. Check the estimates tab for more information on the PDEX EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
PDEX does not pay a dividend.
PRO-DEX INC (PDEX) will report earnings on 2025-04-30, after the market close.
The PE ratio for PRO-DEX INC (PDEX) is 17.27. This is based on the reported non-GAAP earnings per share of 2.01 and the current share price of 34.72 USD. Check the full fundamental report for a full analysis of the valuation metrics for PDEX.
The outstanding short interest for PRO-DEX INC (PDEX) is 0.86% of its float. Check the ownership tab for more information on the PDEX short interest.
ChartMill assigns a technical rating of 2 / 10 to PDEX. When comparing the yearly performance of all stocks, PDEX is one of the better performing stocks in the market, outperforming 93.98% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to PDEX. While PDEX has a great profitability rating, there are some minor concerns on its financial health.
Over the last trailing twelve months PDEX reported a non-GAAP Earnings per Share(EPS) of 2.01. The EPS increased by 168% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 11.06% | ||
ROA | 11.18% | ||
ROE | 21.21% | ||
Debt/Equity | 0.33 |
ChartMill assigns a Buy % Consensus number of 83% to PDEX. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 229.03% and a revenue growth 23.48% for PDEX